Oral administration of clonidine in patients with alcoholic cirrhosis. Hemodynamic and liver function effects

Gastroenterology

Volumn 102, Issue 1, 1992, Pages 248-254

  Albillos, Agustin ^a,b,c   Bañares, Rafael ^a,b,c   Barrios, Cesar ^a,b,c   Clemente, Gerardo ^a,b,c   Rossi, Irma ^a,b,c   Escartin, Pedro ^a,b,c   Bosch, Jaime ^a,b,c  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; GALACTOSE; INDOCYANINE GREEN; PROPRANOLOL;

ADULT; ALCOHOL LIVER CIRRHOSIS; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HEPATIC VEIN; HUMAN; LIVER BLOOD FLOW; LIVER CLEARANCE; LIVER FUNCTION; MALE; MEAN ARTERIAL PRESSURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VENOUS PRESSURE; XEROSTOMIA;

ADMINISTRATION, ORAL; BLOOD PRESSURE; CLONIDINE; FEMALE; GALACTOSE; HEMODYNAMICS; HEPATIC VEINS; HUMAN; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; LIVER FUNCTION TESTS; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; VENOUS PRESSURE;

EID: 0026595277     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(92)91807-G     Document Type: Article

References (28)

1. Effects of propranolol on azygos venous flow and hepatic hemodynamics in cirrhosis
2. The effect of propranolol on portal hypertension in patients with cirrhosis. A hemodynamic study
3. Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model
4. Betablockade with propranolol and hepatic artery flow in patients with cirrhosis
5. Enhancement of portal pressure reduction by the association of isosorbide-5-monitrate to propranolol administration in patients with cirrhosis
6. Effect of propranolol on metabolic activity of the liver in patients with alcoholic cirrhosis
7. Pharmacology of centrally acting hypotensive drugs
8. Sympathetic tone modulates portal venous pressure in alcoholic cirrhosis
9. Hemodynamic effects of a clonidine-induced decrease in sympathetic tone in patients with cirrhosis
10. Transection of the esophagus for bleeding esophageal varices
11. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis
12. The physiological basis for clearance measurements in hepatology
13. Determination of the hepatic elimination capacity (Lm) of galactose by single injection
14. Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: Comparison with the effects on portal pressure
15. Effect of pharmacological agents on portal hypertension: A haemodynamic appraisal
16. Portal pressure, presence of gastroesophageal varices, and variceal bleeding
17. Endoscopic measurement of variceal pressure in cirrhosis: Correlation with portal pressure and variceal hemorrhage
18. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage
19. Measurements of portal pressure and its clinical application
20. Mechanisms of a clonidine-induced decrease in portal pressure in normal and cirrhotic conscious rats
21. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: the hepatic artery buffer response
22. Effect of hepatic nerves, norepinephrine, angiotensin, elevated central venous pressure on postsinusoidal resistance sites and intrahepatic pressures
23. Long-term hemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension
24. Intrinsic hepatic clearance and Child-Turcotte classification for assessment of liver function in cirrhosis
25. Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis
26. The acute effects of inhibition of SNS activity on renal function in cirrhosis (abstr)
27. Antihypertensive agents and the drug therapy of hypertension
28. Short-term effects of propranolol on portal venous pressure